This country profile provides an overview of Namibia’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profile
Priorities for progress in Namibia
- Namibia should work to clarify the epidemiology of bilharzia and intestinal worms in the country, and work to build a preventive chemotherapy programme in line with WHO recommendations.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Namibia does not require mass treatment for elephantiasis.
Namibia may require interventions for blinding trachoma, investigation needed.
Treatment coverage was 21% in 2016 and not reported in 2017.
Treatment coverage was not reported in 2016 or 2017.
Namibia does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Namibia.